about
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals.Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients.Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity.Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.Nevirapine in the treatment of HIV.Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adultsEffect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteers.Pharmacokinetics of phase I nevirapine metabolites following a single dose and at steady state.Lack of clinically significant drug interactions between nevirapine and buprenorphine.Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers.Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management.Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB.
P2860
Q33797850-8EBA4058-4293-4C6D-8D3C-C01B2E9BF8BFQ35598594-CAD54EAB-C76E-4A54-8072-15E5EAEC2527Q35692270-5487F72A-4C03-4FA8-B60C-7B7601234C44Q35738851-AE747969-DEB8-4E13-9CBE-91F7D767E22BQ35826691-28A93632-EEF1-4ED2-8D82-3B66F2DD5439Q35873680-ED3CFCC9-2FF0-4FA4-8B76-D9DFE2364169Q35906594-66F7521D-2582-43DA-B68E-79D5B1729315Q35917412-9951642C-CFB2-4E3C-B6C3-98B5CB0E7FF5Q36300127-4B1144EA-A7AF-42AE-BC61-37DA4E0EC4CCQ36558235-F29E0786-F7E6-48CA-8E51-0121AB5365D3Q36785839-B2090E11-2F6E-440C-BA4D-16558DB69FB6Q37045349-F234B38F-CA46-4330-AA13-810B18D77826Q37096787-062B726E-E7AC-44FA-994A-3D75B43E21ABQ37364219-3508CED4-B0F2-4A74-BC48-39A0C68EE122Q37378110-5D883F3F-EE57-4F2A-94BF-B1C0A7A2983CQ37845854-3BDA3621-F26B-4ACF-9DE1-AACD44414ECDQ40839674-404B7025-902A-40F8-891D-A610FA21F479
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Pharmacokinetic drug interactions with nevirapine.
@en
Pharmacokinetic drug interactions with nevirapine.
@nl
type
label
Pharmacokinetic drug interactions with nevirapine.
@en
Pharmacokinetic drug interactions with nevirapine.
@nl
prefLabel
Pharmacokinetic drug interactions with nevirapine.
@en
Pharmacokinetic drug interactions with nevirapine.
@nl
P2093
P1476
Pharmacokinetic drug interactions with nevirapine.
@en
P2093
David Back
Sara Gibbons
P356
10.1097/00126334-200309011-00003
P407
P478
34 Suppl 1
P577
2003-09-01T00:00:00Z